Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · IEX Real-Time Price · USD
0.568
0.00 (-0.04%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Calidi Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021
Cash & Equivalents
1.950.372.14
Cash & Cash Equivalents
1.950.372.14
Cash Growth
423.92%-82.59%-
Other Current Assets
2.350.410.6
Total Current Assets
4.30.792.74
Property, Plant & Equipment
5.341.090.59
Other Long-Term Assets
0.370.730.07
Total Long-Term Assets
5.721.810.65
Total Assets
10.022.63.39
Accounts Payable
2.882.270.62
Current Debt
1.9234.7320.95
Other Current Liabilities
5.435.994.39
Total Current Liabilities
10.2342.9925.96
Long-Term Debt
5.310.450.04
Other Long-Term Liabilities
2.7100
Total Long-Term Liabilities
8.020.450.04
Total Liabilities
18.2543.4426
Total Debt
7.2435.1820.99
Debt Growth
-79.43%67.58%-
Retained Earnings
-99.57-70.36-44.93
Comprehensive Income
-0.05-0.01-0
Shareholders' Equity
-8.24-50.44-31.61
Net Cash / Debt
-5.29-34.81-18.86
Net Cash Per Share
-0.31-4.09-0.95
Working Capital
-5.93-42.2-23.22
Book Value Per Share
-0.49-5.93-1.60
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).